DePuy Orthopaedics, a unit of Johnson and Johnson, manufactured two of its hip replacement to cater to the needs of those people suffering from unbearable joint pains on the hip, medical experts say. Nowadays, not only aging people are suffering from it but also those who are in younger age,such as those in their early 20s. Unfortunately, it had a different turn out when thousand of recipients of such surgery experience much worse pain for having received defective implants. Several lawsuits had been filed, including one from a woman from Rochester, New York whose case takes the first trial this year.
Usually those patients who undergo hip replacements are those suffering from the debilitating pain of osteoarthritis or from a broken femur due to a serious accident.
Instead of providing solution to the existing joint problems, artificial hip implantation has given patients much worst situation for which revision surgery is considered an option and which surgeons described it as a difficult and painful operation.
After receiving a high volume of unpublished data from a joint replacement registry in the United Kingdom (UK) indicating many patients with the ASR Hip System suffering from several problems, DePuy issued a voluntary recall of its ASR Hip System in 2010.
One of those most feared problems of the DePuy ASR, a metal-on-metal artificial hip replacement, is that it wears down and metal particles may be released from the artificial hip, which may damage the bone and react with the tissues such as the muscle and ligaments surrounding the joint and enter the bloodstream. This is sometimes referred to as an €adverse local tissue reaction (ALTR) or an €adverse reaction to metal debris (ARMD).€ Such a reaction may cause the implant to become loose or cause pain.
This also caused United Kingdom regulator, the Medicine and Healthcare Products Regulatory Agency (MHRA), to issue a product recall for DePuy ASR. This meant that surgeons were told not to implant DePuy ASR hip replacements and return any unused implants to the manufacturer.
The regulator also urged surgeons to tell those recipients of the DePuy ASR hip replacements about the recall and to schedule them for annual follow-up visits and that those experiencing pain should not be taken lightly and surgeons should automatically measure the level of metals in the patient's blood and should examine the soft tissue to see if reactions have occurred. However, if the results shows that the patient has a high level of metals in the bloodstream, then there is a need for the patient to undergo surgery and the need for the painful revision. To know more about related cases, visit the DePuy Hip Recall News Center at depuyrecallnewscenter.com.
Usually those patients who undergo hip replacements are those suffering from the debilitating pain of osteoarthritis or from a broken femur due to a serious accident.
Instead of providing solution to the existing joint problems, artificial hip implantation has given patients much worst situation for which revision surgery is considered an option and which surgeons described it as a difficult and painful operation.
After receiving a high volume of unpublished data from a joint replacement registry in the United Kingdom (UK) indicating many patients with the ASR Hip System suffering from several problems, DePuy issued a voluntary recall of its ASR Hip System in 2010.
One of those most feared problems of the DePuy ASR, a metal-on-metal artificial hip replacement, is that it wears down and metal particles may be released from the artificial hip, which may damage the bone and react with the tissues such as the muscle and ligaments surrounding the joint and enter the bloodstream. This is sometimes referred to as an €adverse local tissue reaction (ALTR) or an €adverse reaction to metal debris (ARMD).€ Such a reaction may cause the implant to become loose or cause pain.
This also caused United Kingdom regulator, the Medicine and Healthcare Products Regulatory Agency (MHRA), to issue a product recall for DePuy ASR. This meant that surgeons were told not to implant DePuy ASR hip replacements and return any unused implants to the manufacturer.
The regulator also urged surgeons to tell those recipients of the DePuy ASR hip replacements about the recall and to schedule them for annual follow-up visits and that those experiencing pain should not be taken lightly and surgeons should automatically measure the level of metals in the patient's blood and should examine the soft tissue to see if reactions have occurred. However, if the results shows that the patient has a high level of metals in the bloodstream, then there is a need for the patient to undergo surgery and the need for the painful revision. To know more about related cases, visit the DePuy Hip Recall News Center at depuyrecallnewscenter.com.